BIMZELX
BIMZELX
Approved
DIN Number
02525267
Drug Class
Human
Market Date
Mar 30, 2022
Company
HC
UCB Canada Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02525267
AIG Number0163399001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L04AC21 BIMEKIZUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification84:06.28
Health Canada Classification
ACTIVE INGREDIENTS (1)
BIMEKIZUMABActive
Strength: 160 MG / ML
Monograph: BIMEKIZUMAB